Systemic AA amyloidosis: epidemiology, diagnosis, and management.
about
Peptide-Induced Amyloid-Like Conformational Transitions in ProteinsThermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre.Gastrointestinal Amyloidosis: Review of the Literature.Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study.A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.Urethral Amyloidosis in a Patient with IgA Nephropathy After Renal Transplant.Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.AA Amylodisis Associated with Jugular Paraganglioma as a Rare Cause of Chronic Diarrhea.A case of localized amyloidosis of the eyelid misdiagnosed as recurrent chalazionPeriorbital Ecchymosis (Raccoon Eye) and Orbital Hematoma following Endoscopic Retrograde CholangiopancreatographyClinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis.Safety and efficacy of empirical interleukin-1 inhibition using anakinra in AA amyloidosis of uncertain aetiology.Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.Distinct Secretory Activity and Clinical Impact of Subcutaneous Abdominal Adipose Tissue in Women with Rheumatoid Arthritis and Osteoarthritis.Response of Bortezomib Chemotherapy in Hepatic Amyloidosis.MRI of pathology-proven peripheral nerve amyloidosis.Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis.Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.Multiple papular lesions in a patient with HIV and/or AIDS and coinfected with hepatitis B virus: Amyloidosis.Inhibitory effect of propolis on the development of AA amyloidosis.Primary Sjogren syndrome diagnosed simultaneously with localized amyloidosis of the lacrimal gland: A case report.Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A
P2860
Q26782224-EF8CE3BA-31EB-45A5-8155-2C8408B297A7Q35886290-17BD1351-014E-4E4E-8A19-5CEE198C5A53Q38689671-9A291A30-82D2-48A8-900F-C0622F204296Q39371045-51DEB241-5973-4362-BD78-7608C2F82A1EQ40073378-A3AAE808-47B2-4A8B-B4FC-1D34AA8BA3E1Q40661190-4AA7F279-EFAD-4BEA-8BBF-15023557229DQ40986637-C264682A-5C11-408E-A07E-EE479F59F66EQ41106725-560F529F-741E-43E6-AF54-B4D055E548E8Q41437808-9875EC35-4559-4FF3-90CE-6F18345A3E81Q41505897-E0F45AAF-7D6D-4402-BC2C-07D8D96B7DA1Q42158508-CB47114C-9666-4191-886A-E1F16BB8021DQ45903141-BD1BE265-B028-40B1-9160-0C1E853BBBCCQ47306597-349CFC3C-26B2-4B7B-A640-FD2B82506901Q49917457-866B55AC-C297-4A2C-B6E7-184FEC1B074FQ51354466-BFC7F255-7B43-4493-BCB9-B2D0B8BD15B4Q52649453-9A859120-C52F-4375-87F3-E9BD474B58E5Q53011553-1969C0D3-2B3B-4806-BCD3-05F96DE26C10Q53174546-5F1CCDA7-789B-4678-8548-F7979B3725FFQ53279630-6867C027-8512-4897-B652-3C948723AB5CQ53695989-2BFDB411-0CEE-43BE-9299-DD18B6126992Q53699100-4BF80A35-58DD-4689-83B3-56F50C104AF7Q54082926-A24301D7-DBEF-4C79-BDE5-06353CD263B1Q55285618-FDC455C6-3CFB-4831-BE5E-A7BD6EBF4DD6Q58134438-82CA67DF-5321-43E4-BA13-060CEBB7D0AC
P2860
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
@ast
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
@en
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
@nl
type
label
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
@ast
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
@en
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
@nl
prefLabel
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
@ast
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
@en
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
@nl
P2093
P2860
P356
P1476
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
@en
P2093
Davinia Trujillo
Diego Real de Asúa
Jose María Galván
Julen Cadiñanos
María Teresa Filigheddu
Ramón Costa
P2860
P304
P356
10.2147/CLEP.S39981
P407
P577
2014-10-29T00:00:00Z